By Michael Dabaie

 

Boston Scientific Corp. (BSX) said the U.S. Food and Drug Administration gave 510(k) clearance of the Exalt Model D Single-Use Duodenoscope for use in endoscopic retrograde cholangiopancreatography procedures.

The EXALT Model D Duodenoscope is a disposable duodenoscope and was granted Breakthrough Device Designation from the FDA, Boston Scientific said.

The device was been developed as an alternative to reusable duodenoscopes, eliminating the need for duodenoscope reprocessing and repairs, and allowing physicians to use a new, sterile device for every procedure.

The company plans to commence a limited market release of the device in the U.S. during the first quarter of 2020.

 

Write to Michael Dabaie at michael.dabaie@wsj.com

 

(END) Dow Jones Newswires

December 13, 2019 13:59 ET (18:59 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Boston Scientific Charts.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Boston Scientific Charts.